AKBLF (Alk-Abello AS) Total Assets : $1,157.8 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Alk-Abello AS Total Assets?

Alk-Abello AS's Total Assets for the quarter that ended in Dec. 2024 was $1,157.8 Mil.

During the past 12 months, Alk-Abello AS's average Total Assets Growth Rate was 22.50% per year. During the past 3 years, the average Total Assets Growth Rate was 10.80% per year. During the past 5 years, the average Total Assets Growth Rate was 7.60% per year. During the past 10 years, the average Total Assets Growth Rate was 8.20% per year.

During the past 13 years, Alk-Abello AS's highest 3-Year average Total Assets Growth Rate was 15.00%. The lowest was 4.60%. And the median was 8.00%.

Total Assets is connected with ROA %. Alk-Abello AS's annualized ROA % for the quarter that ended in Dec. 2024 was 8.59%. Total Assets is also linked to Revenue through Asset Turnover. Alk-Abello AS's Asset Turnover for the quarter that ended in Dec. 2024 was 0.19.

Alk-Abello AS Total Assets Historical Data

The historical data trend for Alk-Abello AS's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Total Assets Chart

Alk-Abello AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

909.67

885.88

898.20

984.08

1,157.81

Alk-Abello AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															984.08	988.95	1,016.07	1,064.16	1,157.81

Alk-Abello AS Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Alk-Abello AS's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	754.412	+	403.392
	=	1,157.8

Alk-Abello AS's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	754.412	+	403.392
	=	1,157.8

Alk-Abello AS (OTCPK:AKBLF) Total Assets Explanation

Total Assets is connected with ROA %.

Alk-Abello AS's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	95.476	/	( (1064.156	+	1157.805)	/ 2 )
	=	95.476	/	1110.9805
	=	8.59 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Alk-Abello AS's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	210.472	/	( (1064.156	+	1157.805)	/ 2 )
=	210.472	/	1110.9805
=	0.19

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Alk-Abello AS Total Assets Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alk-Abello AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (OTCPK:AKBLF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

0OIR:UK ALK B:Denmark 4AJ0:Germany

Address

Boge Alle 6-8, Horsholm, DNK, DK-2970

Website

https://www.alk.net

Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.